Researchers have identified pathways in acute myeloid leukaemia (AML) resistance to FLT3 inhibitors, offering hope of new treatments.
According to the international team working on the project, a new generation of drugs could now prevent the resis...
1 year ago
Swiss researchers have revealed that mutations of the TP53 gene harm the prognosis for patients with acute myeloid leukaemia (AML) treated with chimeric antigen receptor (CAR)-T cell therapies.
However, in a proof-of-concept study, the Zurich-base...
1 year ago
